MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RKDA has $5,323K in assets. $2,438K in debts. $954K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
378.68%
Quick Ratio
317.14%
Cash Ratio
69.89%
Debt to Asset Ratio
45.80%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable and other re...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
954 259 1,120 1,376
Current assets of discontinued operations - goodwheat
-0 0 0
Short-term investments
2,766 4,304 4,765 3,067
Accounts receivable and other receivables, net of allowance for credit loss of 559 as of march 31, 2026 and december 31, 2025
425 425 831 1,264
Note receivable - current, net of allowance for credit losses (note 8)
-0 0 0
Inventories
840 1,212 1,457 1,489
Prepaid expenses and other current assets
184 156 214 383
Total current assets
5,169 6,356 8,387 7,579
Property and equipment, gross
-1,907 --
Less accumulated depreciation and amortization
-1,899 --
Property and equipment, net
0 8 10 12
Right of use assets
-0 0 10
Note receivable - noncurrent, net of allowance for credit losses (note 8)
-0 0 0
Intangible assets, net
39 39 39 39
Other noncurrent assets
115 143 148 148
Total assets
5,323 6,546 8,584 7,788
Other current liabilities-Related Party
-0 0 0
Operating lease liability - current
-0 0 11
Accounts payable and accrued expenses
1,102 1,789 2,015 1,558
Other current liabilities
263 270 270 270
Total current liabilities
1,365 2,059 2,285 1,839
Other noncurrent liabilities
-0 0 0
Common stock warrant and option liabilities
1,073 347 856 1,416
Total liabilities
2,438 2,406 3,141 3,255
Common stock, 0.001 par value - 150,000,000 shares authorized as of march 31, 2026 and december 31, 2025 2,056,884 and 1,373,120 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
66 65 65 -
Additional paid-in capital
288,421 285,292 285,259 -
Accumulated deficit
-285,602 -281,217 -279,881 -
Total stockholders' equity
2,885 4,140 5,443 4,533
Total liabilities and stockholders equity
5,323 6,546 8,584 7,788
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$2,766K Cash and cashequivalents$954K Inventories$840K Accounts receivable andother receivables,...$425K Prepaid expenses andother current assets$184K Total current assets$5,169K Other noncurrentassets$115K Intangible assets, net$39K Total assets$5,323K Total liabilities andstockholders equity$5,323K Total stockholders'equity$2,885K Total liabilities$2,438K Accumulated deficit-$285,602K Additional paid-in capital$288,421K Total currentliabilities$1,365K Common stock warrantand option...$1,073K Common stock, 0.001 parvalue - 150,000,000...$66K Accounts payable andaccrued expenses$1,102K Other currentliabilities$263K

Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc. (RKDA)